AXL and cancer: Targeting AXL using the monoclonal antibody hMAb173 induces apoptosis in both ex vivo and in vivo models.73 These findings suggest that AXL plays a significant role in cancer cell proliferation and survival, making it a promising therapeutic target to inhibit cancer growth and enhance apoptosis in a range of malignancies.